Showing results (101-110 of 346) with videos related to
Sort By:
Pageof 35
Blood Pressure Monitoring|February 3, 2005
Recommendations for blood pressure measuring devices for office/clinic use in low resource settingsGianfranco Parati, Shanthi Mendis, Dele Abegunde, et al.Vaccines|May 28, 2022
The Impact of COVID Vaccination on Symptoms of Long COVID: An International Survey of People with Lived Experience of Long COVIDWilliam David Strain, Ondine Sherwood, Amitava Banerjee, et al.Circulation. Arrhythmia and Electrophysiology|August 28, 2012
Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation projectGregory Y H Lip, Amitava Banerjee, Isabelle Lagrenade, et al.Diabetes, Obesity & Metabolism|June 9, 2022
Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney diseaseIskandar Idris, Ruiqi Zhang, Jil B Mamza, et al.Open Heart|September 27, 2023
Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record studyLaura Pasea, Ashkan Dashtban, Mehrdad Mizani, et al.International Journal of Cardiology|September 18, 2015
Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort studyAndrew D Blann, Amitava Banerjee, Deirdre A Lane, et al.Diabetes, Obesity & Metabolism|May 11, 2021
Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary careIskandar Idris, Ruiqi Zhang, Jil Billy Mamza, et al.The Lancet Regional Health. Europe|March 13, 2023
Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort studyCharlotte Warren-Gash, Jennifer A Davidson, Helen Strongman, et al.Plos One|March 29, 2018
Personalized survival predictions via Trees of Predictors: An application to cardiac transplantationJinsung Yoon, William R Zame, Amitava Banerjee, et al.Journal of Medical Internet Research|September 12, 2025
A Design Framework for Microintervention Software Technology in Digital Health: Critical Interpretive SynthesisDan Roland Persson, Mel Ramasawmy, Nushrat Khan, et al.Pageof 35